Literature DB >> 16826461

Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid.

Noboru Okamura1, Shuichi Ohnishi, Hiroyuki Shimaoka, Ryo Norikura, Hiroshi Hasegawa.   

Abstract

PURPOSE: Prodrugs with pivalic acid and valproic acid decrease L-carnitine concentration in plasma and tissues by urinary excretion of acylcarnitine as pivaloylcarnitine (PC) and valproylcarnitine (VC), respectively. We investigated the role of the Na+/L-carnitine cotransporter in the porcine kidney epithelial cell line, LLC-PK1 for the decrease of L-carnitine concentration.
METHODS: The uptake of L-[3H]carnitine, acetyl-L-[3H]carnitine (AC), L-[3H]PC and L-[3H]VC were investigated in LLC-PK1 cells seeded in a 6-well culture plate.
RESULTS: L-Carnitine and AC uptake in LLC-PK1 cells exhibited Na+ dependency. The Km values for L-carnitine and AC uptake were 11.0 and 8.18 microM, respectively. These results indicated expression of Na+/ L-carnitine cotransporter in LLC-PK1 cells. PC and VC inhibited Na+/L-carnitine cotransporter in the competitive (Ki = 90.4 microM) and noncompetitive (Ki = 41.6 microM) manners, respectively. PC and VC uptake by Na+/L-carnitine cotransporter were not observed in LLC-PK1 cells.
CONCLUSIONS: These data suggested that PC and VC formed in the body could not be reabsorbed in the kidney, resulting in the decrease of L-carnitine concentration. In addition, inhibition of L-carnitine reabsorption by VC with lower Ki value could induce the decrease of L-carnitine concentration. Collectively, the recognition and interaction of Na+/L-carnitine cotransporter are important factors for carnitine homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16826461     DOI: 10.1007/s11095-006-9002-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

1.  Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.

Authors:  B Melegh; J Kerner; V Jaszai; L L Bieber
Journal:  Biochem Med Metab Biol       Date:  1990-02

2.  Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.

Authors:  A Marzo; E Arrigoni Martelli; R Urso; M Rocchetti; V Rizza; J G Kelly
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Carnitine deficiency induced by pivampicillin and pivmecillinam therapy.

Authors:  E Holme; J Greter; C E Jacobson; S Lindstedt; I Nordin; B Kristiansson; U Jodal
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

4.  Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.

Authors:  Y Wang; J Ye; V Ganapathy; N Longo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 5.  Carnitine metabolism and its regulation in microorganisms and mammals.

Authors:  C J Rebouche; H Seim
Journal:  Annu Rev Nutr       Date:  1998       Impact factor: 11.848

6.  Pivampicillin-promoted excretion of pivaloylcarnitine in humans.

Authors:  B Melegh; J Kerner; L L Bieber
Journal:  Biochem Pharmacol       Date:  1987-10-15       Impact factor: 5.858

7.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

8.  Protein binding of L-carnitine family components.

Authors:  A Marzo; E Arrigoni Martelli; A Mancinelli; G Cardace; C Corbelletta; E Bassani; M Solbiati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991       Impact factor: 2.441

9.  Transcellular transport of organic cation across monolayers of kidney epithelial cell line LLC-PK.

Authors:  H Saito; M Yamamoto; K Inui; R Hori
Journal:  Am J Physiol       Date:  1992-01

10.  Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs.

Authors:  K Mizojiri; S Futaguchi; R Norikura; Y Katsuyama; T Nagasaki; T Yoshimori; M Nakanishi
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  7 in total

1.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

2.  Set-base dynamical parameter estimation and model invalidation for biochemical reaction networks.

Authors:  Philipp Rumschinski; Steffen Borchers; Sandro Bosio; Robert Weismantel; Rolf Findeisen
Journal:  BMC Syst Biol       Date:  2010-05-25

3.  Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.

Authors:  Patrick Forny; Friederike Hörster; Diana Ballhausen; Anupam Chakrapani; Kimberly A Chapman; Carlo Dionisi-Vici; Marjorie Dixon; Sarah C Grünert; Stephanie Grunewald; Goknur Haliloglu; Michel Hochuli; Tomas Honzik; Daniela Karall; Diego Martinelli; Femke Molema; Jörn Oliver Sass; Sabine Scholl-Bürgi; Galit Tal; Monique Williams; Martina Huemer; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2021-03-09       Impact factor: 4.750

4.  Transport of L-carnitine in human corneal and conjunctival epithelial cells.

Authors:  Shunjiang Xu; Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark D Willcox; Qian Garrett
Journal:  Mol Vis       Date:  2010-09-04       Impact factor: 2.367

Review 5.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010

Review 6.  Clinical characteristics of primary carnitine deficiency: A structured review using a case-by-case approach.

Authors:  Loek L Crefcoeur; Gepke Visser; Sacha Ferdinandusse; Frits A Wijburg; Mirjam Langeveld; Barbara Sjouke
Journal:  J Inherit Metab Dis       Date:  2022-02-03       Impact factor: 4.750

Review 7.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.

Authors:  Matthias R Baumgartner; Friederike Hörster; Carlo Dionisi-Vici; Goknur Haliloglu; Daniela Karall; Kimberly A Chapman; Martina Huemer; Michel Hochuli; Murielle Assoun; Diana Ballhausen; Alberto Burlina; Brian Fowler; Sarah C Grünert; Stephanie Grünewald; Tomas Honzik; Begoña Merinero; Celia Pérez-Cerdá; Sabine Scholl-Bürgi; Flemming Skovby; Frits Wijburg; Anita MacDonald; Diego Martinelli; Jörn Oliver Sass; Vassili Valayannopoulos; Anupam Chakrapani
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.